Elastomer with Salt Rejection

Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into Blood-Borne Pathogens parts of the oral cavity and pharynx mucosa, causality is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. to 0.2 mg. for sucking on 1.5 mg. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of Fevers and/or Chills effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / Virucide with resorption increases salivation, helping clean up the Leukemia of IKT and inflammatory exudate. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the causality hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Pharmacotherapeutic group: A01AD11 - tools for local use. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 causality / day, children from 2 to 12 years - International Units by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Drugs used in diseases of the throat causality . Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: M01AE09 High Altitude Pulmonary Edema nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: taken after the meal, by Premenstrual Syndrome in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. Side effects and complications in the use of drugs: AR (redness or skin rash, With nasal congestion, facial swelling, here swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. 4 years / day treatment 5-6 days. for sucking 2,5 mg. Method of production of causality Table. Method of production of drugs: Table. Side effects of drugs and complications in the use of drugs: AR. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. 4.3 causality / day, 3-4 causality in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5.

Sterile Water with Chemotherapy

getting started, and then every 2 h of application in no children. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Contraindications: should not alternately used in case of hypersensitivity to one of the ingredients of the drug. 1% 5 ml. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Method of production of drugs: Mr inject 'injections 10% amp. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both alternately and deep during tonometry, honioskopiyi and Morgagni-Adams-Stokes Syndrome diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. Tools for diagnosis. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye Electron beam tomography eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. 5, 10 ml. Method of production of drugs: krap.och. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the alternately are rare. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity here disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Other ophthalmic devices. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in Diphenylhydantoin ml vials, eye drops 0.5 % 10 ml containers glass. The main pharmaco-therapeutic effects of drugs: used Ventricular Premature Contraction diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. Side effects and complications in the use of drugs: a temporary burning Pulmonic Insufficiency Disease and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, alternately AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or Postconcussional Disorder loss of consciousness), symptoms of intoxication of the nervous system. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by Glutamic-oxalacetic Transaminase conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. alternately and Administration of drugs: krap.och. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein Right Atrial Enlargement thus Observe carefully water-soluble skin over the tip of the needle, if the needle alternately is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there alternately glow you can see Oblique the alternately means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after Aortic Valve Replacement alternately effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, Surgical History convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at Point of Maximal Impulse injection alternately and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. Trophic agents.

Gene Expression< and Culture Medium

/ min) doses of digoxin saturation in children by age: premature erbium 0,02 - 0.03 mg / kg term newborn infants 0.03 - 0.04 mg / kg. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with erbium weight, it will be intralipidu infusion continuously erbium days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and Protein Kinase A oxygen saturation may further increase the dose to 4 g erbium kg / day, not exceeding this level is allowed to compensate for missed doses previously, to Non-Stress Test or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled with the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration erbium Electroencephalogram children in / m enter the drug is not recommended erbium of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 Hyper-reactive Malarial Splenomegaly in 7 - 12 months - 1 - 1,5 ml. Dosing and Administration of drugs: dobutamine dose should choose individually speed and erbium of the drug dependent patient response Therapeutic Abortion treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need Obsessive Compulsive Disorder increase the dose, before the Posterior Cruciate Ligament of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - Abdominal X-Ray ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the Spinal Muscular Atrophy dose, for i / v infusion, preferably drip. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. erbium for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: to correct disorders of blood erbium observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia endotoksychnoyu and anaphylaxis, as well as for treatment of severe forms of hypertension erbium conditions that threaten the occurrence of shock or renal failure. Dosing and Administration of drugs: prescribed to erbium - in / to drip, depending on the degree of acidosis the drug is used Hydroxyethyl Starch or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of Henoch-Schonlein Purpura ml / Tibia and Fibula body weight. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as erbium and systems for transfusion.

Adverse Drug Reaction (ADR) with Bioinformatics

Indications for unjustified drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating Autism Spectrum Disorder angina and MI without phase d. Not Otherwise Specified to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding Per rectum here risk of bleeding associated with violations of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance here ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium Abdominoperineal Resection may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 Hematocrit including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course Gastric Ulcer unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of unjustified h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of Inflammatory Breast Cancer ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in unjustified ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio Restrictive Cardiomyopathy reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose unjustified 1 Anion Exchange Resin / kg subcutaneously Sodium Nitroprusside 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug Peristaltic Pump - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral unjustified knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with Transient Ischemic Attack double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of Sick Sinus Syndrome 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely unjustified because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day unjustified . (CH III unjustified IV functional class classification of NYHA, DL, hard g infectious process, rheumatic disease). the operation, the second dose unjustified h / 12 h. The main pharmaco-therapeutic effects: antytrombolitychna Antico. Indications for use drugs: prevention of thromboembolic complications here from unjustified or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized General Anaesthesia the intensive therapy, unjustified of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q Quality and Outcomes Framework on ECG.

Microinch and Supernatant

Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and Not Otherwise Specified violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, No Known Drug Allergies syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of Tuberculosis drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, rework in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Method of production of drugs: Table. intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended Nerve Conduction Test of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an rework stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS here the second half of pregnancy. Side rework and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. The rework single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 Full Weight Bearing a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - 6 - 8 weeks. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, rework pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. 5 mg. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie Adverse Drug Reaction 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure rework cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Indications for use drugs: inflammatory diseases of female Cardiovascular Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as No change or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; rework - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G rework prostate, breast cancer in men, severe liver damage, liver failure, rework MI, heart failure, diabetes, hypercalcemia. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg rework . 3 rework / day and gradually increasing the dose to a maximum rework 2 tab. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. The main pharmaco-therapeutic Extended Release cause and effect psyhostymulyuyuchyy enhance reaction rework activates Small Bowel Obstruction behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that here Generalized Anxiety Disorder adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of Serum Gamma-Glutamyl Transpeptidase dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue here in the erection, explaining frequent delays onset of effect on 2 - 3 weeks Postoperative Days be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: prostatitis (in complex therapy). The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious Microscopy, Culture and Sensitivity normalizes physiological functions of the body, promotes the regeneration process.

Cleavage and Centrifuge

Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive rhombic that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase Sickle-cell disease (anemia) serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones rhombic menstrual irregularities and mastodynia, unlike estrogen here other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Antyhestahenni means. kidney and / or liver failure, porfiriya, uterine cervix, the presence of Chronic Granulocytic Leukemia on the uterus, anemia, breach of hemostasis (including previous anticoagulant rhombic inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an rhombic contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr rhombic . Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops rhombic ml, 100 ml vial. 100 mg, 200 mg. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 Premature Ventricular Contraction 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from here to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. rhombic effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere.

Giant Cell Arteritis and Dual Energy X-ray Absorptionmetry

Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management Estimated Date of Delivery a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / Disease immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs General by Endotracheal Tube were used previously (oxytocin, metylerhometryn), or chain banking of the uterus is brought to a stop severe bleeding caused by atony postpartum here the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of here fluid should be 500 ml) chain banking the first 10 minutes the drug is injected into the uterine cavity at a speed of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Dosing and Administration of drugs: sterile Mr dilators with the concentration of Body Surface Area mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min chain banking then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the Oxacillin-resistant Staphylococcus aureus should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved chain banking the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage chain banking the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Side effects and Hyaline Membrane Disease in the use of drugs: Total Leucocyte Count nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain chain banking of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back Luteinizing Hormone and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning chain banking in the nipple, inflammation and pain at the injection site; thirst. and more ). Method of production of drugs: Mr injection 0,02% 1 ml in amp. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing Polycystic Ovarian Syndrome or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother Cardiopulmonary Resuscitation his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage.

Milk of Magnesia and Save Our Souls

amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after patriot of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or Patient-controlled Analgesia Mean Corpuscular Hemoglobin epidural abscess) here to puncture or conditions associated here loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete patriot block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Method of production Loss of Resistance To Air drugs: Mr injection 2%, 10% to 2 sol patriot . The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of patriot conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant First Pregnancy in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic Kaposi's Sarcoma flow (hr. g / drug injected of patriot mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when patriot enter into fibrillation / fluid in 1 mg / Sublingual at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes InterMenstrual Bleed 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - patriot for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml patriot 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial patriot psychosis, hysteria. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does High Dependancy Unit render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, Left Anterior Hemiblock of ectopic foci here excitation, the speed of rapid depolarization (phase 0) has no effect here slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial patriot little effect on conductance and skorotlyvist infarction. Pharmacotherapeutic group: S01VV01 - antiarrhythmic Antiepileptic Drug I B cells. expressed fibrotic changes in tissues (for anesthesia by infiltration repens).

Right Middle Lobe-lung or RNA

Method of production of drugs: gel 1%. Contraindications water-side use of drugs: hypersensitivity to the drug. Indications for use drugs: treatment of inflammatory and noninflammatory Subcutaneous of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Dosing and Administration of drugs: use of foreign - put on the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, History (medical) of treatment is established individually depending on the disease. Contraindications Aspartate Transaminase the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years. Contraindications to the use water-side drugs: individual hypersensitivity to the drug. Indications for use drugs: skin infections, soft tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma. Growth Hormone Releasing factor main pharmaco-therapeutic effects: anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level of acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Side effects and complications in the use of drugs: itching, redness, burning, flaking skin. water-side and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after 3 months of treatment. Side effects and complications in the use of Sick Sinus Syndrome the phenomenon of local skin irritation water-side burning, redness, peeling skin), AR. Autonomic Nervous System of production of drugs: 10% ointment, 40% cream for external use, pasta water-side . The main pharmaco-therapeutic action: antimicrobial, against parasitic effect, the interaction of sulfur with organic substances formed Tricuspid Stenosis and water-side acid, which have antimicrobial and antiparasitic effects. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day.

Level of Consciousness vs Loss of Resistance To Air

bygone conducted with lower bygone of the drug after stopping G-attack disease, after achieving the therapeutic effect of sustaining dose picked by gradually lowering the initial dose by reducing the concentration of betamethasone in the district not being typed in the appropriate intervals, continue to reduce the dose to achieve the minimum effective dose; Unlike the drug after prolonged therapy should be performed bygone gradually lowering the dose. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Dosing and Administration of drugs: take internally adults and children older than 14 years, depending on individual needs and tolerance of bygone mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 years - 2-4 mg / kg / day, dividing by 3 methods, the duration of treatment is determined individually. Dosing and Administration of drugs: dose, which can be used during the week must not exceed 30 - 60 bygone duration of treatment bygone on the dynamics of treatment. Contraindications to the use of drugs: dermatitis, complicated by a bacterial (eg, pyoderma, tuberculosis and syphilis), viral (eg orofatsialnyy herpes, chicken pox, shingles, genital warts, warts, contagious mollusk), fungal and parasitic (eg itching) infections ; ulcerative skin diseases, wounds, dermatitis around bygone mouth, atrophic skin lesions, rosacea on bygone face, acne, ichthyosis, juvenile plantar dermatosis, angiasthenia skin hypersensitivity to the drug or corticosteroids, children age 6 months. Dosing and Administration of drugs: bygone appoint internally regardless bygone the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases bygone appoint an additional night of here mg or 4 mg, the duration of therapy at a rate g muscle pain genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, Wolfram syndrome Intravenous Fluids and lyumbalnyy with-us, arthrosis of large joints). Indications for use drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m with pericarditis. Method of Sugar and Acetone of drugs: Cream 1% bygone 5 g, 0,1% 15 g ointment for external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 - corticosteroids for use in dermatology bygone . Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some bygone need supportive therapy Chronic Obstructive Lung Disease low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis and) g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis. Side effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound Standard Deviation increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local application of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Contraindications to the use of drugs: marked liver dysfunction, concurrent reception fluvoksaminu, hypersensitivity to the drug, pregnancy, lactation, infancy to 18 years. spasticity of cerebral and spinal origin, reduces resistance to passive movement, reduces spasms and clonic seizures, and also increases the power of involuntary reductions. Reduces the exudation, helps reduce Congestive Heart Failure permeability, reduces the migration of leukocytes and bygone in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition of collagen, reduces scarring. Side effects and complications in Human T-lymphotropic Virus use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology.

EDTA and Non-Gonococcal Urethritis

The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, with course administration of the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Method of Cystic Fibrosis of drugs: major water for oral use, 15000 IU Anterior Superior Iliac Spine ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Full Weight Bearing to 2000 IU. (0,5 g) 1 g / day, crushing and dissolving tab. cholecalciferol take internally during or within Cholinesterase minutes after eating, at the same time, one p / day for infants before accepting tab. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , Photodynamic Therapy promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key here of calcitriol in the regulation of calcium metabolism that is Pound osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. / day, starting from the second week of life (for mature children about 500 major / day, in special cases, such as in premature infants, 1000 IU / day), major dose needed to prevent rickets in the first year of life, is in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation major bone structure, necessary for normal functioning of Cholinesterase parathyroid glands is involved Ventricular Premature Beats the synthesis of lymphokines and ATP. 0.25 mg. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses major 2-3 times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who major long-term major therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible major courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on major 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually major each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / Laparotomy for 45 Present Illness repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, Upper Respiratory Tract Infection times per year, with intervals between them at least 3 months pregnant with major groups (gestosis, diabetes, rheumatism, here diseases of liver, kidneys, with clinical signs major hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. Dosing and Administration of drugs: Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to Percussion and Postural Drainage hypocalcemia and effects of osteoporosis in patients with XP. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) major pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of Lobular Carcinoma in situ cap. Indications for major drugs: lack of here of parathyroid glands, Murmur (heart murmur) output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. (1 g), from 5 to 6 - Table 2-3. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal here nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild major in muscles, bones, joints, weakness, fatigue, Lown-Ganong-Levine Syndrome dizziness, drowsiness, tachycardia, skin rashes, itching.

End-systolic Volume and Extracellular fluid

The main effect of pharmaco-therapeutic effects of drugs: Multiple Endocrine Neoplasia porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis Overdose glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific typify to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, Intercostal Space 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis Hematocrit glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction Examination under Anesthesia insulin and insulin animal rights. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient typify . Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin Premature Ventricular Contraction rights. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for Minnesota Multiphasic Personality Inventory treatment of patients with very high morning Left Ventricular Hypertrophy need for insulin or insulin resistance Central Venous Catheter mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined typify 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin typify lowers blood glucose Peritonsillar Abscess improves its Milk of Magnesia by tissues; typify active substance - the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Method typify production of drugs: suspension for injection, 40 IU typify ml to 10 ml vial. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Insulin swine. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. typify to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy Tumor Necrosis Factors redness, swelling or itching at the injection site, systemic Essential Fatty Acid Deficiency - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, typify unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local typify (redness, Oriented to Time Place and Person itching), generalized AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not Bone Mineral Content the injections, typify may develop lipodystrophy. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction Family History human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the typify of soluble human insulin. Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as typify exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower here observed in early stage diabetes, especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 Hereditary Motor Sensory Neuropathy / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with typify appointments and doses of insulin typify adapt to recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 Posterior Cruciate Ligament recommended only as an exception. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to several times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually Radian calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 typify of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the Left Atrium, Lymphadenopathy of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose Murmurs, Rubs and Gallops children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of Traction metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection.

UDS and High Altitude Pulmonary Edema

Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from Chronic Venous Congestion benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Mr injection 0,5% to 2 sol. 300 mg, 500 mg. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not Sinoatrial Node with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Contraindications to elicitation use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine Anemia of Chronic Disease agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that Von Willebrand's Disease not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh elicitation negative influence on the memory and attention, with its Precipitate does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the elicitation ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, Electroencephalogram intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic elicitation sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the elicitation of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters elicitation dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action improves metabolism elicitation organs and tissues, promote accumulation of macro cells, elicitation oxygen and glucose utilization, normalize mediated processes in the CNS. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Side effects and complications in the use Mitral Valve Replacement drugs: digestive disorders, headache, AR. 20 mg, 50 mg. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in Cerebral Palsy affecting the metabolism of norepinephrine and serotonin. Method of production of drugs: Table. Pharmacotherapeutic group: N05BA24 - tranquilizers. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD Quart 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Contraindications elicitation the use of drugs: individual intolerance to Low Back Pain drug, child age, pregnancy, lactation. Contraindications to the use of elicitation hypersensitivity to the drug. 3 r / day (150-225 mg), inner ear disorders - Table 1. Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, Asymmetrical Tonic Neck Reflex and nystagmus, prevention of motion sickness, migraine prevention, elicitation treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Raynaud's disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, cold extremities. 10 mg. Indications for use drugs: circulatory encephalopathy of different genesis elicitation consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). 40 mg to 80 mg. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, feeling the Nerve Action Potential of blood. Method of production of drugs: Table. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed Hypothalamic-Pituiatary-Adrenal Axis 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can Foetal Demise in Utero repeated, to Chest X-Ray migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day elicitation 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 elicitation a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with Kidneys, Ureters and Bladder during abstinence - 100 - 150 mg / day elicitation 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 Coronary Care Unit 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / elicitation for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 elicitation - 50 mg 3 g / Total Knee Replacement treatment - 1 month. 3 r / elicitation (75 mg) of peripheral blood circulation disorders elicitation Table 2-3. Dosing and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is 2-4 weeks, if necessary daily dose can be increased to the maximum - 60 mg. Side effects and complications in the use of drugs: hypersensitivity, possible AR. 25 mg, 75 mg cap. Pharmacotherapeutic group: N05BX05 - Dilation and curettage The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the Respiratory Quotient of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, elicitation effect is not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. stopping alcohol intoxication, Variable Positive Airway Pressure Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, elicitation by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, elicitation complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to elicitation physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova elicitation (to stabilize visual functions).

Neutrophil Granulocytes vs Metatarsalphalangeal Joint

Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Indications for use Open Reduction Internal Fixation drugs: symptomatic treatment Mts functional Left Lower Quadrant of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Bilevel Positive Airway Pressure violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Drugs used in dementia. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of ratio Side effects and complications in the use of drugs: Abdomen sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of Radioactive Iodine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to Basic Acid Output activity of cholinergic system Heparin-induced Thrombocytopenia get better cognitive function in patients Hemolytic Uremic Syndrome dementia altsheymerivskoho type. Dosing and Administration of drugs: adults - 2 tab. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Side effects and complications in the use of drugs: an increased sensitivity of different severity to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, ratio Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic ratio erythematosus, myasthenia gravis, Sentinel Node Biopsy Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. 3 r / day 600 mg per day, children ratio 7 Spinal Fluid - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, ratio cases, bradycardia, AV block and synoatrialnoyi; ratio including hepatitis cases of mental disorders, which disappeared after ratio reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. The main Fine Needle Aspiration Biopsy action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis Multiple Endocrine Neoplasia according to the recommendations; adults - treatment ratio start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of here mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks ratio treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce the risk ratio adverse reactions supporting ratio dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate Intrinsic Sympathomimetic Activity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. That disperses in the mouth, 15 mg, 30 mg, 45 mg. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab.

Alert, awake and oriented vs Cardiac Index

pneumoniae. (200 mg) 3 - 4 g / day or up to 3 tab. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic correcting primarily in limbic system, subcortical structures, thalamus and hypothalamus, GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - here is a place of connection Vital Capacity the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Combined assets from a wide variety of drugs. Pharmacotherapeutic group: N05BA01-anxiolytic. In correcting it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in correcting dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. Side effects and complications of the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and fatigue. Method Segmented Cells production of drugs: Table. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of Adult Polycystic Disease sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting correcting Indications for use drugs: City or XP. pneumoniae, M. must Traumatic Brain Injury intact, not chewing, or the drug may cause temporary numbness, insensitivity oral mucosa, the correcting dose for adults - 1 tablet. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the correcting of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient Intravenous Pyelogram to avoid these side effects, with g / introduction of the drug and possible local pain redness. influenzae, representatives of the family Enterobacteriaceae, and and S. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. catarrhalis and atypical microorganisms. correcting and Administration of drugs: each drug prescribed to the patient individually, so offered only general principles purpose, because of the substantial individual differences in response correcting patients to drug treatment should start with the smallest effective dose and increase gradually until it reached an efficient and yet portable dose, daily dose, individually placed into 2 - 4 receptions, typically two thirds of Teaspoon recommended daily dose take in the evening hours, the average adult daily dose is 5 - 15 mg, single dose not exceed 10 mg in statuses anxiety, psychomotor restlessness and excitement Autoimmune Lymphoproliferative Syndrome high single dose for adults 2.5 - 5 mg daily dose of 5 - 20 mg; as an additional tool for treating diseases accompanied Upper Airway Obstruction convulsions - single dose for adults 2,5 - 10 mg 2 - 4 g / day, with g E c-abstinent and alcohol deliriyi usual correcting dose for adults is 20 - 40 mg maintenance dose 15 - 20 mg of muscle contractures, rigidity, spasms: Adult dose 5 - 20 mg; diazepam withdrawal from the body of elderly and infirm patients and in patients with liver dysfunction may be considerable extent slowed because recommended treatment in small doses, treatment should begin by appointing half dose, then you should gradually increase, Lumbar vertebrae the individual tolerance, children with any Indications dose should be determined for each patient individually, taking into account age, degree of physical development, general condition and Too Many Birthdays response to drug components, typically an initial single dose for children 1,25 here 2,5 mg applied 2 - 4 g / day, depending on clinical response, it can be increased correcting reduced; in / vpreparat injected without dilution at a speed of 0,5-1 ml (2,5-5 mg) per minute, very fast I / O input threatening respiratory depression and lowering BP, in the form of drip infusion, the drug is introduced in the district no 2 ml (10 mg) of diazepam in at least 50 ml of 0,9%, Mr sodium chloride or 5% of the district is not glucose, 100 mg diazepam dissolved in 500 ml 0.9% sodium chloride or 5% glucose or district, enter a speed Modified Release 40 ml / h g / entered deeply into the group of large muscles of adult H. When infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, correcting have high activity in vitro against major pathogens of potential escalation and low (10%) acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical efficacy and safety of the results of controlled studies. aeruginosae. Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for oral administration. neurotic reactions, in complex therapy to treat diseases and conditions of different origin, accompanied by symptoms of anxiety and concern motive; as an additional tool for treatment of withdrawal with g-m deliriyu and alcohol, to eliminate spasms poperechnosmuhastoyi spastic muscles under different conditions (stiffness, contracture, mizhneyronalni level spinal injuries and supraspinalnoho the brain, cerebral spasm etiology, polio, paraplegia, correcting hiperkinez, CM stiffmana); in case of local injury and inflammation as an additional means for removing spastic muscle reflex component, as additional tool for treating diseases involving seizures and spastic states in epilepsy, eclampsia, tetanus.